Epigenica granted €150,000 from the ERC for a 2nd time

Epigenica has been awarded a Proof-of-Concept grant of €150,000 to begin commercialization of a new platform technology. The ERC PoC hmqPro will focus on developing novel highly-multiplexed, quantitative biomarker profiling.

Published
Categorised as News